1. CD44-SLC1A2 Fusion Transcripts in Primary Colorectal Cancer
   Kazuya Shinmura et al, 2015, Pathology & Oncology Research CrossRef
2. Inhibitory effect of MSH6 gene silencing in combination with cisplatin on cell proliferation of human osteosarcoma cell line MG63
   Hu‐Cheng Liu et al, 2019, Journal of Cellular Physiology CrossRef
3. Genomic alterations in Turcot syndrome: Insights from whole exome sequencing
   Philipp Karschnia et al, 2020, Journal of the Neurological Sciences CrossRef
4. Worldwide prevalence of Lynch syndrome in patients with colorectal cancer: Systematic review and meta-analysis
   Nadine Abu-Ghazaleh et al, 2022, Genetics in Medicine CrossRef
5. A Genetic Perspective on Colorectal Cancer Progression
   Lenuce Ribeiro Aziz Ydy et al, 2019, Multidisciplinary Approach for Colorectal Cancer CrossRef
6. Lynch syndrome identification in a Brazilian cohort of endometrial cancer screened by a universal approach
   Reginaldo Cruz Alves Rosa et al, 2020, Gynecologic Oncology CrossRef
7. Rare compound heterozygous mutations in gene MSH6 cause constitutive mismatch repair deficiency syndrome
   Chao Ling et al, 2018, Clinical Case Reports CrossRef
8. Worldwide variation in lynch syndrome screening: case for universal screening in low colorectal cancer prevalence areas
   George Kunnackal John et al, 2021, Familial Cancer CrossRef
9. Integrating surgical intervention and watch-and-wait approach in dMMR metastatic rectal cancer with pembrolizumab: a case report
   Yohei Ando et al, 2024, Surgical Case Reports CrossRef
10. Lower prevalence of Lynch syndrome in colorectal cancer patients in a Japanese hospital-based population
    Kensuke Kumamoto et al, 2016, Surgery Today CrossRef
11. Heterogenous loss of mismatch repair (MMR) protein expression: a challenge for immunohistochemical interpretation and microsatellite instability (MSI) evaluation
    Aoife J McCarthy et al, 2019, The Journal of Pathology: Clinical Research CrossRef
12. MSH6, Past and Present and Muir–Torre Syndrome—Connecting the Dots
    Meera Mahalingam, 2017, The American Journal of Dermatopathology CrossRef
13. Germline variants screening of MLH1, MSH2, MSH6 and PMS2 genes in 64 Algerian Lynch syndrome families: The first nationwide study
    Asma‐Lamia Boumehdi et al, 2022, Annals of Human Genetics CrossRef
14. Population-based Screening for Hereditary Colorectal Cancer Variants in Japan
    Masashi Fujita et al, 2022, Clinical Gastroenterology and Hepatology CrossRef
15. Lynch Syndrome Caused by a Germ Line Mutation in MSH6
    Okihide Suzuki et al, 2015, The Japanese Journal of Gastroenterological Surgery CrossRef
16. High tumor mutational burden and T-cell activation are associated with long-term response to anti-PD1 therapy in Lynch syndrome recurrent glioblastoma patient
    Elena Anghileri et al, 2021, Cancer Immunology, Immunotherapy CrossRef
17. Comparison of universal screening in major lynch-associated tumors: a systematic review of literature
    George Kunnackal John et al, 2022, Familial Cancer CrossRef
18. Protein profiles reveal MSH6/MSH2 as a potential biomarker for hepatocellular carcinoma with microvascular invasion
    Shengqian Hong et al, 2024, Hepatology Research CrossRef
19. Emerge of colorectal cancer in Lynch syndrome despite colonoscopy surveillance: A challenge of hide and seek
    Noah C. Helderman et al, 2024, Critical Reviews in Oncology/Hematology CrossRef